Sign inJoin waitlistJoin the waitlist

Daniel Ontaneda

Fellowship Associate Director · Cleveland Clinic Foundation

Credentials: · · · ·

History

Cleveland Clinic Foundation
Present

Case Western Reserve University School of Medicine
Case Western Reserve University School of Medicine
2016–2020
Cleveland Clinic
2011–2012
Cleveland Clinic
2006–2010

Research

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
Review · Nature Reviews Neurology · 2016 · 328 citations
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Review · The Lancet Neurology · 2025 · 326 citations
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
New England Journal of Medicine · 2018 · 231 citations

Jeffrey Cohen
42 papers
Robert Fox
32 papers
Daniel Reich
29 papers
Nancy Sicotte
24 papers
Robert Bermel
24 papers
Andrew Solomon
23 papers
MA
Moein Amin
20 papers · 16 as a resident
Peter Calabresi
20 papers
Christina Azevedo
16 papers
Devon Conway
15 papers
Kedar Mahajan
15 papers · 3 as a fellow
LF
Leorah Freeman
15 papers · 2 as a resident

Grants

Susceptibility Based MRI Biomarkers for Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · R56
Contact PI · $549.5K · Cleveland Clinic Lerner Com-Cwru
2026–2027
Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $7.1M · Cleveland Clinic Lerner Com-Cwru
2020–2026

Clinical trials

Central Vein Sign in Multiple Sclerosis Extension Study
Principal investigator · Recruiting
The Cleveland Clinic
2025–2027
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
Principal investigator · Active not recruiting
The Cleveland Clinic
2020–2027
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Principal investigator · Active not recruiting · Phase 4
The Cleveland Clinic
2019–2027